Collectively, the findings from molecular, cellular, and proteomics-based studies converge on the conclusion that JTB protein is a complex and context-dependent regulator in BC, with the capacity to function both as an oncogene and a tumor suppressor. The gene discussed is JTB; the disease is neoplasm.